A66 PROTON PUMP INHIBITORS AND THE RISK OF INFLAMMATORY BOWEL DISEASE: A REAL WORLD POPULATION-BASED COHORT STUDY

por Yanofsky, R P, Abrahami, D, Pradhan, R, Yin, H, McDonald, E G, Bitton, A, Azoulay, L
Publicado 2023

COVID-19 in a patient with idiopathic pulmonary fibrosis successfully treated with Ruxolitinib

por Caradec, E., Mouren, D., Zrounba, M., Azoulay, L.-D., Blandin, C., Ivanoff, S., Levy, V., Brillet, P.-Y., Nunes, H., Uzunhan, Y.
Publicado 2021